NewslettersPulmonary Cell NewsCombination of Esomeprazole and Pirfenidone Enhances Antifibrotic Efficacy In Vitro and in a Mouse Model of TGFβ-Induced Lung FibrosisBy Jamie Kang - November 30, 20220158Investigators evaluated the anti-fibrotic efficacy of the proton pump inhibitor esomeprazole when combined with pirfenidone in vitro and in vivo.[Scientific Reports]Full Article